Health-related quality of life in patients with Chagas disease: a review of the evidence

Health-related quality of life in patients with Chagas disease: a review of the evidence

Chagas disease (ChD), a neglected tropical disease caused by infection with the parasite Trypanosoma cruzi (T. cruzi), remains a serious public health issue in Latin America and is an emerging disease in several non-endemic countries, where knowledge of the condition and experience with its clinical...

Full description

Bibliographic Details
Main Authors:	Giovane Rodrigo Sousa, Henrique Silveira Costa, Aline Cristina Souza, Maria Carmo Pereira Nunes, Márcia Maria Oliveira Lima, Manoel Otávio da Costa Rocha
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2015-04-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Chagas disease Quality of life Health-related quality of life Cardiomyopathy Determining factors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000200121&lng=en&tlng=en

Similar Items

Health-Related Quality of Life Reported by Patients With Chagas Disease: A Systematic Review of Qualitative Evidence With GRADE Recommendations
by: Whesley Tanor Silva, et al.
Published: (2022-12-01)

Biomakers in Chronic Chagas Cardiomyopathy
by: Angela Braga Rodrigues, et al.
Published: (2022-08-01)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy
by: Lucas Frois Fernandes Oliveira, et al.
Published: (2021-11-01)

Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges
by: Henrique Silveira Costa, et al.
Published: (2020-07-01)

Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial
by: Marcelo Carvalho Vieira, et al.
Published: (2024-04-01)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
by: Germano Carneiro Costa, et al.

Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
by: Henrique S Costa, et al.
Published: (2018-08-01)

Exercise-induced ventricular arrhythmias and vagal dysfunction in Chagas disease patients with no apparent cardiac involvement
by: Henrique Silveira Costa, et al.
Published: (2015-04-01)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
by: Elieusa e Silva Sampaio, et al.

Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function
by: Whesley Tanor Silva, et al.
Published: (2020-11-01)

Reassessment of quality of life domains in patients with compensated Chagas heart failure after participating in a cardiac rehabilitation program
by: Mauro Felippe Felix Mediano, et al.

Evaluating respiratory musculature, quality of life, anxiety, and depression among patients with indeterminate chronic Chagas disease and symptoms of pulmonary hypertension
by: Alícia Cristina Suman, et al.

Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial
by: Mauro F. F. Mediano, et al.
Published: (2023-01-01)

Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial
by: Mauro F. F. Mediano, et al.
Published: (2023-09-01)

Chagas disease and perceived quality of life: a cross-sectional study
by: Nayara Ragi Baldoni, et al.
Published: (2023-10-01)

Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2023-12-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.

Health-related quality of life in patients with Chagas disease Qualidade de vida relacionada à saúde na doença de Chagas
by: Bruna Guimarães Oliveira, et al.
Published: (2011-04-01)

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysis
by: Sindhu Chadalawada, et al.
Published: (2021-12-01)

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
by: Claudia Di Lorenzo Oliveira, et al.
Published: (2020-03-01)

The Burden of Chagas Disease in the Contemporary World: The RAISE Study
by: Antonio Luiz Pinho Ribeiro, et al.
Published: (2024-01-01)

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
by: Isis G. Montalvo-Ocotoxtle, et al.
Published: (2022-12-01)

Reduced functional capacity in patients with Chagas disease: a systematic review with meta-analysis
by: Henrique Silveira Costa, et al.

Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease
by: Amanda Fortes Francisco, et al.
Published: (2023-11-01)

Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al.

Associação entre dissinergia miocárdica e arritmia ventricular na forma indeterminada da doença de Chagas Association between left ventricular wall motion abnormalities and ventricular arrhythmia in the indeterminate form of Chagas disease
by: Márcio Lins Barros, et al.
Published: (2011-04-01)

Immunosuppressive drugs as a tool to explore immunopathology in experimental Chagas disease
by: KS Calabrese
Published: (1999-09-01)

Chagas Disease: From Discovery to a Worldwide Health Problem
by: Kárita Cláudia Freitas Lidani, et al.
Published: (2019-07-01)

Death due to acute Chagas -related myocarditis in a child: a case report
by: Theresa Cristina Cardoso da Silva, et al.
Published: (2020-04-01)

Adverse drug events and the associated factors in patients with chronic Chagas disease
by: Luiza Braz da Cunha Lopes, et al.
Published: (2020-04-01)

Circulating microRNAs as biomarkers of Chagas cardiomyopathy
by: Laura Antonietti, et al.
Published: (2023-12-01)

Acometimento cardíaco em Casos de Doença de Chagas Aguda da Amazônia Cardiac involvement in Acute Chagas' Disease Cases in the Amazon region
by: João Marcos Barbosa-Ferreira, et al.
Published: (2010-06-01)

T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
by: Eula G. A. Neves, et al.
Published: (2022-02-01)

Avaliação do metabolismo dos fosfatos de alta energia em pacientes com doença de Chagas Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease
by: Ana Maria Betim Paes Leme, et al.
Published: (2010-08-01)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain
by: Sithu Win, et al.
Published: (2022-08-01)

Anatomopathological Aspects of Acute Chagas Myocarditis by Oral Transmission
by: Dilma do Socorro Moraes de Souza, et al.
Published: (2016-07-01)

Immunopathology of cardiomyopathy in the experimental Chagas disease
by: Milena BP Soares, et al.
Published: (1999-09-01)

Serum cytokines in chronic Chagas' disease
by: Ward Laura S., et al.
Published: (1999-01-01)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Luis E. Echeverría, et al.
Published: (2021-11-01)